Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059).
Simon A RuleGuillaume CartronChristopher FeganFranck MorschhauserLingling HanSiddhartha MitraGilles Andre SallesMartin J S DyerPublished in: Leukemia (2019)
Keyphrases